An alternative miRISC targets a cancer‐associated coding sequence mutation in FOXL2.

GLO:1VT/16aug21:embj2021108163-toc-0001.jpg PHOTO (COLOR): . gl The authors note that I P i values presented in the original Fig 1A and Appendix Fig S1A were not assessed using a proper statistical analysis method. In contrast to the initially employed two-group I t i -test, a one-sample one-tailed I t i -test is appropriate here, as the basic null hypothesis is that the proportion of MT I FOXL2 i mRNA in each AGCT patient is lower than WT { I H i SB 0 sb : WT(%) > MT(%) }. An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2. [Extracted from the article]